Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 5 February 2026 Transaction in Own Shares The Company announces that on 4 February 2026 it bought back 240,000 of its own shares, to be held as treasury shares, at an average price of 1492 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,593,722Total shares in issue excluding treasury shares following settlement of this purchase: 61,960,470 The Company has bought back these shares under the authority granted by shareholders at its Annu...
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 4 February 2026 Transaction in Own Shares The Company announces that on 3 February 2026 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1555 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,353,722Total shares in issue excluding treasury shares following settlement of this purchase: 62,200,470 The Company has bought back these shares under the authority granted by shareholders at its Annua...
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 3 February 2026 Transaction in Own Shares The Company announces that on 2 February 2026 it bought back 4,000 of its own shares, to be held as treasury shares, at an average price of 1533 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,338,722Total shares in issue excluding treasury shares following settlement of this purchase: 62,215,470 The Company has bought back these shares under the authority granted by shareholders at its Annual...
Stormy times at present – a sunnier outlook? Undoubtedly, 2025 was a difficult year for Infrastructure Investment Companies (IICs) and Renewable Energy Infrastructure Funds (REIFs). Investors have seen underperformance against the FTSE 100, widening NAV discounts, several delistings, managed wind-downs (MWDs) and regulatory issues both in the UK and in the US. The question for investors is: where do we go from here? On the one hand, yields for some REIFS are well over twice those of 10-year gil...
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 2 February 2026 Transaction in Own Shares The Company announces that on 30 January 2026 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1532 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,334,722Total shares in issue excluding treasury shares following settlement of this purchase: 62,219,470 The Company has bought back these shares under the authority granted by shareholders at its Ann...
Voting Rights and Capital ICG Enterprise Trust plc (the “Company”) 2 February 2026 Total Voting Rights In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows. At the close of business on 31 January 2026, the Company had 63,554,192 Ordinary shares in issue, of which 1,314,722 were held in Treasury. Therefore, the total number of voting rights in the Company is 62,239,470.The above figure 62,239,470 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their ...
Q3 update for the three months ended 31 October 2025 ICG Enterprise Trust plc30 January 2026Q3 update for the three months ended 31 October 2025 Highlights NAV per Share of 2,080p (31 Jul 2025: 2,040p)Q3 NAV per Share Total Return of 2.4%Continuing strong realisation activity: £82m Total Proceeds in Q3Q3 Total New Investments of £25m, bringing YTD Total New Investments to £138mRobust balance sheet: 3% gearing ratio, £230m total available liquidityQ3 dividend of 9p per share; Board increases FY26 dividend guidance to 39p per share (FY25: 36p)In the three years since the launch of the long-te...
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 30 January 2026 Transaction in Own Shares The Company announces that on 29 January 2026 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1534 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,324,722Total shares in issue excluding treasury shares following settlement of this purchase: 62,229,470 The Company has bought back these shares under the authority granted by shareholders at its Annua...
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 21 January 2026 Transaction in Own Shares The Company announces that on 20 January 2026 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1489 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,314,722Total shares in issue excluding treasury shares following settlement of this purchase: 62,239,470 The Company has bought back these shares under the authority granted by shareholders at its Annua...
AUCTUS PUBLICATIONS ________________________________________ Condor Energies (CDR CN)C; Target price of C$5.60 per share: Uzbekistan production boost: two new wells onstream in February – The first horizontal well is now onstream. Only the shallower interval has been tested to date, delivering 3.6 mmcf/d. The full ~1 km lateral — including the zones with the strongest gas‑show responses — has not yet been accessed. A larger‑diameter coiled‑tubing unit than is currently available is required to d...
The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. After three years of annual declines, the HHI rebounded 17.6% to 469.1 in 2025. While this sounds positive, it was below the strong performance of most major UK healthcare stocks and, in general, it underperformed its UK and peer benchmarks: FTSE 100 (+21.5%); FTSE All-Share (+19.8%); and the NASDAQ Biotech Index (NBI; +32.4%). Th...
This month’s feature article is the Hardman & Co Healthcare Index written by Dr Martin Hall, Head of Life Sciences at Hardman & Co. The main function of the HHI is to monitor the performance, and to highlight the attractiveness, of life sciences investments over the long term, and to try to identify those stocks that have disruptive technologies that consistently allow them to outperform both the index and the markets. Many of the 49 constituents of the index are high-risk, with micro-capitali...
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 6 January 2026 Transaction in Own Shares The Company announces that on 5 January 2026 it bought back 140,000 of its own shares, to be held as treasury shares, at an average price of 1500 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,304,722Total shares in issue excluding treasury shares following settlement of this purchase: 62,249,470 The Company has bought back these shares under the authority granted by shareholders at its Annual...
Voting Rights and Capital ICG Enterprise Trust plc (the “Company”) 5 January 2026 Total Voting Rights In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows. At the close of business on 31 December 2025, the Company had 63,554,192 Ordinary shares in issue, of which 1,164,722 were held in Treasury. Therefore, the total number of voting rights in the Company is 62,389,470.The above figure 62,389,470 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify th...
Pantheon has released its full year results to the end of June 2025. The company’s focus remains on forward planning for its Alaska assets, both in terms of considering restart of flow testing at Dubhe-1 in the spring, and progression across the wider portfolio, including potential Kodiak appraisal.
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 30 December 2025 Transaction in Own Shares The Company announces that on 29 December 2025 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1495 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,164,722.Total shares in issue excluding treasury shares following settlement of this purchase: 62,389,470. The Company has bought back these shares under the authority granted by shareholders at its A...
Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 24 December 2025 Transaction in Own Shares The Company announces that on 23 December 2025 it bought back 10,000 of its own shares, to be held as treasury shares, at an average price of 1495 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 1,154,722Total shares in issue excluding treasury shares following settlement of this purchase: 62,399,470 The Company has bought back these shares under the authority granted by shareholders at its Ann...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.